Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
37
MNKD Quote, Financials, Valuation and Earnings
Last price:
$5.55
Seasonality move
:
-5.29%
Day range:
$5.62 - $5.77
52-week range:
$3.38 - $6.51
Dividend yield:
0%
P/E ratio:
60.08x
P/S ratio:
5.57x
P/B ratio:
--
Volume:
2.1M
Avg. volume:
3.8M
1-year change:
1.98%
Market cap:
$1.7B
Revenue:
$285.5M
EPS (TTM):
$0.09
Analysts' Opinion
-
Consensus RatingMannKind Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.61, MannKind Corp. has an estimated upside of 69.81% from its current price of $5.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.50 representing -- downside risk from its current price of $5.66.
Fair Value
-
According to the consensus of 8 analysts, MannKind Corp. has 69.81% upside to fair value with a price target of $9.61 per share.
MNKD vs. S&P 500
-
Over the past 5 trading days, MannKind Corp. has overperformed the S&P 500 by 1.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MannKind Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MannKind Corp. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter MannKind Corp. reported revenues of $82.1M.
Earnings Growth
-
MannKind Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MannKind Corp. reported earnings per share of $0.03.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
5.57x
EV / EBIT:
22.33x
EV / Revenue:
5.43x
PEG ratio (5yr expected):
1.76x
EV / Free cash flow:
39.86x
Price / Operating cash flow:
40.87x
Enterprise value / EBITDA:
19.61x
Gross Profit (TTM):
$235.9M
Return On Assets:
6.72%
Net Income Margin (TTM):
9.32%
Return On Equity:
--
Return On Invested Capital:
24.75%
Operating Margin:
22.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $176.5M | $267.2M | $313.8M | $70.1M | $82.1M | |
| Gross Profit | $115.7M | $192.1M | $235.9M | $52.1M | $61.9M | |
| Operating Income | -$9.4M | $57.3M | $76.3M | $15.2M | $18.8M | |
| EBITDA | -$3.8M | $65.1M | $86.9M | $17.8M | $21.5M | |
| Diluted EPS | -$0.12 | $0.07 | $0.09 | $0.04 | $0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $159.2M | $218.4M | $225.6M | $327.7M | $358.8M | |
| Total Assets | $238.2M | $293.8M | $320.3M | $464.2M | $494.6M | |
| Current Liabilities | $50M | $59.6M | $96.4M | $72.1M | $109.1M | |
| Total Liabilities | $422.9M | $531.5M | $572.1M | $674.1M | $539.2M | |
| Total Equity | -$184.7M | -$237.7M | -$251.8M | -$209.9M | -$44.6M | |
| Total Debt | $287.5M | $383.6M | $382.4M | $344.9M | $187.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.9M | $41.2M | $48.2M | $9.3M | $23.5M | |
| Cash From Investing | $20.9M | -$152.8M | $35.4M | -$41.3M | -$25.1M | |
| Cash From Financing | -$2.1M | $91.6M | -$18.6M | -$2.3M | $72M | |
| Free Cash Flow | -$31.8M | $28.5M | $42.7M | $7.8M | $22.4M | |
MNKD
Sector
Market Cap
$1.7B
$24M
Price % of 52-Week High
--
48.29%
Dividend Yield
0%
0%
Shareholder Yield
1.42%
-1.6%
1-Year Price Total Return
1.98%
-22.92%
Beta (5-Year)
0.839
0.500
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.73
200-day SMA
Buy
Level
$4.92
Bollinger Bands (100)
Buy
Level
5.28 - 5.84
Chaikin Money Flow
Sell
Level
-330.4M
20-day SMA
Sell
Level
$5.71
Relative Strength Index (RSI14)
Sell
Level
48.16
ADX Line
Sell
Level
12.23
Williams %R
Neutral
Level
-71.7647
50-day SMA
Sell
Level
$5.75
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
230.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.0402)
Sell
CA Score
(Annual)
Level (-3.5074)
Sell
Beneish M-Score
(Annual)
Level (-1.1939)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.5596)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Stock Forecast FAQ
In the current month, MNKD has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNKD average analyst price target in the past 3 months is $9.61.
-
Where Will MannKind Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that MannKind Corp. share price will rise to $9.61 per share over the next 12 months.
-
What Do Analysts Say About MannKind Corp.?
Analysts are divided on their view about MannKind Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MannKind Corp. is a Sell and believe this share price will drop from its current level to $7.50.
-
What Is MannKind Corp.'s Price Target?
The price target for MannKind Corp. over the next 1-year time period is forecast to be $9.61 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MNKD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MannKind Corp. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MNKD?
You can purchase shares of MannKind Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MannKind Corp. shares.
-
What Is The MannKind Corp. Share Price Today?
MannKind Corp. was last trading at $5.55 per share. This represents the most recent stock quote for MannKind Corp.. Yesterday, MannKind Corp. closed at $5.66 per share.
-
How To Buy MannKind Corp. Stock Online?
In order to purchase MannKind Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MNKD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MNKD
Sector
P/E ratio
60.08x
23.25x
PEG ratio
1.76x
-0.01x
P/B ratio
--
1.73x
Price / LTM sales
5.57x
1.51x
Growth Metrics
MNKD
Sector
Revenue growth
17.2%
3.51%
Earnings growth
-36.95%
11.14%
Revenue (5-year growth)
35.27%
6.27%
Earnings forecast
$0.03
-$0.19
Profitability
MNKD
Sector
Profitability FY 2024
$208.9M
$2.7M
Return on invested capital
24.75%
-33.58%
Return on assets
6.72%
-29.74%
Return on equity
--
-38.98%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
MNKD
Sector
Total cash
$260M
$24.9M
Short term investments
$150.9M
$23.9M
Total assets
$393.8M
$71.6M
Long term debt
$187.8M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 17
Cooper-Standard Holdings, Inc. [CPS] is down 3.36% over the past day.
Buy
58
TPH alert for Feb 17
Tri Pointe Homes, Inc. [TPH] is down 0.24% over the past day.
Sell
20
IRON alert for Feb 17
Disc Medicine, Inc. [IRON] is up 17.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
